A new study suggests that American men are much more likely than women are to be unaware that they suffer from high blood pressure. African-American men with the condition are at the highest risk, with only one in seven both aware of their illness and able to control it through medication.
More: continued here
Healthy individuals with higher levels of albumin excretion, even levels considered normal, are at increased risk of developing hypertension (high blood pressure), according to a study appearing in the October 2008 issue of the Journal of the American Society Nephrology (JASN). The study suggests that to prevent cardiovascular disease, the definition of “normal” urinary albumin excretion should be reconsidered.
More: continued here
Working hard when fatigued may be admired by many Americans, but it is a virtue that could be harmful to one’s health, according to new research by psychologists at the University of Alabama at Birmingham (UAB). The research supports a theory which suggests that exhausted individuals’ cardiovascular systems are forced to work harder when they attempt to complete tasks, such as those encountered on the job or at school.
More: continued here
Protherics PLC “Protherics” or the “Company”), the international biopharmaceutical company focused on critical care and cancer, today announces that the first patient has been enrolled in a phase 2a study of its Angiotensin Therapeutic Vaccine (ATV) for the treatment of hypertension.
More: continued here
A research project at the University of Leicester in conjunction with the University of East Anglia, indicates that early reduction of high blood pressure following stroke is feasible and safe, and both Labetalol & Lisinopril were found to be suitable a medications for this purpose. Larger studies will now be necessary to confirm this result and test the effects on recovery from stroke.
More: continued here
The results of two new studies of Micardis® (telmisartan) in free combination with amlodipine or fixed combination with hydrochlorothiazide (HCTZ) 25 mg confirm that a telmisartan-based approach to treating hypertensive patients at risk of cardiovascular events can provide powerful and sustained blood pressure control in a broad range of people, including those who are difficult-to-treat.
More: continued here
Pfizer Inc announced that it has entered into an agreement with generics manufacturer Ranbaxy Laboratories Ltd. of India and certain of its affiliates to settle substantially all their patent litigation worldwide involving Lipitor, the world’s most-prescribed cholesterol-lowering
More: continued here
The Medicines Company (NASDAQ: MDCO) today announced that data from two post-hoc analyses of the ECLIPSE trial showed that use of Cleviprex™ (clevidipine butyrate) injectable emulsion to control blood pressure during cardiac surgery may be associated with a reduced risk of heart attack compared to two of three currently used IV antihypertensive agents. In a separate sub-analysis, Cleviprex was associated with a lower 30-day mortality compared to two nitrovasodilators.
More: continued here
Insomniacs who sleep fewer than five hours a night are five times more likely to suffer hypertension than people who sleep well, according to a major study that highlights the growing concerns over links between sleep problems and serious illness.
More: continued here
Results of a new analysis of the Treating to New Targets (TNT) study show that intensive low-density lipoprotein (LDL) cholesterol-lowering
More: continued here
